医学科学研究和报告

In Patients with Diabetic Feet, Flap Monitoring in Conjunction with Incisional Negative Pressure Wound Therapy

Abstract

Debbie Wong

For patients with diabetic foot ulcers, many types of flaps are taken into consideration as reconstructive solutions. However, due to the relatively low levels of collateral circulation in the distal lower extremities, flap reconstruction for the treatment of diabetic foot ulcers is particularly difficult. In order to treat diabetic foot, this study assessed the effectiveness and safety of a novel postoperative monitoring technique used in conjunction with negative pressure wound care right after flap procedures. Patients with diabetic feet who underwent free flap and perforator flap procedures between March 2019 and August 2021 were the subject of a retrospective investigation. The rates of complications and survival following surgery were the outcomes of interest.

Patients underwent computed CT angiography on the third postoperative day to look for pedicle compression or fluid accumulation in the sub-flap plane. tracking time, Analyses were done on NPWT and conventional technique comparisons. A statistical comparison between the two groups was done. 26 patients were involved in the study. Patients in the negative pressure wound therapy treated group had 14 flaps, while those in the group receiving standard monitoring had 12 flaps. The flap survival rate did not change significantly across groups (p = 0.83). Additionally, before and after negative pressure wound therapy, there was no discernible intergroup difference in the diameters of perforators or anastomosed arteries (p = 0.97).

Up until the fifth postoperative day, flap monitoring with incisional negative pressure wound therapy was connected to a noticeably decreased mean monitoring time per flap than traditional monitoring. Although standard monitoring is often advised, particularly for the management of diabetic foot ulcers, the innovative incisional negative This study's pressure wound therapy allowed for simple serial flap monitoring without raising the risk of complications. For diabetic foot patients, the innovative flap monitoring technology is effective and secure, making it a promising contender for acceptance as the industry's gold standard in the future.